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Figure: Inhibition of MMP-13 production. *Signiﬁcantly different
(p < 0.001).
The ability of APS to block MMP-13 production better than PRP is
likely due to its increased concentrations of anti-inﬂammatory cytokines.
Previous studies have shown APS has a greater fold increase of anti-
inﬂammatory cytokine concentrations from WB (see the table).
PRP APS
IL-1ra 3.2× 5.6×
sTNF-RI 2.4× 3.8×
sTNF-RII 2.6× 3.8×
Conclusions: APS has been shown to inhibit production of MMP-13,
a protein known to be responsible for cartilage degradation, more
effectively than WB or PRP. This is likely because APS contains higher
concentrations of anti-inﬂammatory cytokines. These results suggest that
APS may be more effective as a potential treatment for early OA, and
further studies are warranted.
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Purpose: Anterior cruciate ligament (ACL) injuries are common,
potentially disabling and frequently prompt surgical reconstruction.
While the number of persons undergoing ACL reconstruction annually
is published, the proportion of ACL injured individuals who undergo
ACL reconstruction has not been examined rigorously. Our objectives
were to assess the 3-year cumulative incidence of ACL reconstruction
among those with ACL injury and to compare demographic and clinical
characteristics of those ACL injured patients that do and do not go on to
have ACL reconstruction.
Methods: We used a tertiary healthcare system Research Patient Data
Repository to identify patients diagnosed with an ACL injury (ICD-9
844.2) at Brigham and Women’s Hospital (BWH) between January 1,
2001 and January 1, 2008. We obtained follow-up data through 2011
to determine how many of those with ACL injury underwent ACL
reconstruction within three years of ACL injury diagnosis. We used
stratiﬁed analyses to examined incidence rates separately by sex, age,
and race. We built logistic regression models to estimate the likelihood
of ACL reconstruction among those with ACL injury adjusted for sex, age,
and race.
Results: There were 2,290 patients diagnosed with an ACL injury at
BWH between 2001 and 2008. The sample was 48% female and 52%
male and the average age was 47 (13.9). The 3-year cumulative of
incidence of ACL reconstruction after ACL injury was 28% (95% CI: (26.3%-
30.0%)). The majority of patients undergoing reconstruction did so within
6 months of injury diagnosis (87%) while 95% of patients underwent
reconstruction within 1 year. Men were more likely than women to have
ACL reconstruction following ACL injury (32% vs 24%). The likelihood of
reconstruction among ACL injured patients decreased with each decade
of age: 52% of 20–29 year olds had reconstruction compared to 10%
of 60–69 years olds. Whites were more likely to have reconstruction
than non-whites (29% vs 20%). Multivariable models showed signiﬁcant
associations between reconstruction and age, sex, and race. Men had 1.4
times the adjusted odds of reconstruction compared to women (95%CI:
(1.1–1.7)); Whites had 1.8 times the adjusted odds of reconstruction
compared to non-Whites (95% CI: (1.3–2.4)); and each decade of age
was associated with 0.6 times the adjusted odds of reconstruction
(95% CI: (0.51–0.62)). Stratiﬁed analyses (see Figure) show that among
patients less than 29, ACL injured females are more likely to undergo
reconstruction than ACL injured males, whereas among ACL injured
patients 30–60 males are more likely to undergo surgery.
Figure: Proportion with ACL reconstruction among those with an injury.
Conclusions: To our knowledge this is the ﬁrst study to report the 3-year
cumulative incidence rates of ACL reconstruction among those diagnosed
with an ACL injury. The odds of having an injury repaired are lower for
women and non-Whites, even after adjusting for age. The decrease in
ACL reconstruction in older ages could reﬂect differences in patients’
willingness to undergo surgery or in physicians’ assessment of clinical
need for surgery. These data could be used to estimate age/sex/race
speciﬁc prevalence of ACL injury in the US.
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CHONDROCYTE GENETIC TYPING IN MASSIVE FRESH
OSTEOCHONDRAL ALLOGRAFT AT 18 MONTHS AFTER
TRANSPLANTATION: ARE THE CELLS STILL FROM THE DONOR?
S. Neri, F. Vannini, R. Buda, A. Rufﬁlli, M. Cavallo, G. Desando, B. Grigolo,
A. Facchini, S. Giannini. Istituto Ortopedico Rizzoli, Bologna, Italy
Purpose: Early post-traumatic arthritis poses a reconstructive challenge
for the young active patient. Fresh total shell osteochondral allograft
(FTSOA) represents a fascinating solution. Still, the survivorship of the
transplanted cartilage has not been fully investigated. Few reports exist
claiming the long term survivorship of the donor chondrocytes and the
inhability of the host cells to colonize the cartilage layer. Aim of this study
was to investigate the nature of the cells in the transplanted cartilage by
genetic typing at 18 months follow up after transplantation.
Methods: Eighteen patients, aged 42±12 years, received FTSOA, 3 of
total knee and 15 of total ankle. Cartilage biopsies were obtained during
revision (18±5 months) or second look surgeries (18±8 months) and
evaluated by histological and immunohistochemical analyses. Allograft
genetic typing compared to recipient and donor DNA was performed on
all the samples by microsatellite analysis. In addition, mRNA expression
of speciﬁc cartilage markers was evaluated on selected samples by Real-
Time RT-PCR.
Results: The 3 knee allografts were analyzed at revision for failure, while
12 out of 15 ankle allografts were analyzed at second look surgeries and
3 at revision for failure.
Histology and immunohistochemistry. All the three knee biopsies showed
the presence of cartilage tissue with many degenerative features
as conﬁrmed by immunohistochemical analyses of the presence of
some catabolic markers. For what is concerning ankle allografts,
cartilage specimens showed ﬁbrocartilagineous tissues with double
tidemark crossed by bundles of cells from subchondral bone;
immunohistochemical analyses revealed a strong positivity for type II
collagen at the extracellular level in the majority of the samples.
Genetic typing and mRNA expression. All the cartilage tissues from knee
allografts showed a mixed DNA proﬁle conﬁrming the presence of both
donor and recipient cells. On the contrary, almost all ankle allografts
typed (12 out of 15, including the three cases of failure) showed the
presence of recipient DNA into the allograft; 1 allograft showed a mixed
DNA proﬁle and 2 allografts matched with donor DNA proﬁle. Preliminary
